COVID-19 Death Toll Surpasses a Million in Latin America

COVID-19 Death Toll Surpasses a Million in Latin America
The death toll from the covid-19 in Latin America and the Caribbean has now surpassed 1 million.

In a statement released on May 21, the Pan American Health Organization (PAHO) said that as of May 21, nearly 89 percent of deaths in Latin America and the Caribbean occurred in Brazil (44.3 percent), Mexico (22.1 percent), Colombia (8.3 percent), Argentina (7.3 percent) and Peru (6.7 percent). Three percent of the deaths were concentrated in Central America and one percent in the Caribbean.

As of May 31, Brazil had more than 462,000 deaths attributed to the epidemic, the second-highest death toll globally after the United States. With more than 329,000 deaths, India ranks second in the region, followed by Mexico with more than 223,000 deaths.

This aerial photo shows a burial at an area where new graves have been dug at the Nossa Senhora Aparecida cemetery in Manaus in the Amazon forest in Brazil on April 22, 2020.

Currently, the PAHO has delivered more than 12 million doses of vaccines procured through the World Health Organization’s COVID-19 Vaccines Global Access initiative to Latin America and the Caribbean, with an additional 770,000 doses being shipped to these areas.

According to the data of the PAHO, several Latin American countries, including Chile, El Salvador, Brazil, and Uruguay, rely almost entirely on vaccines produced in China.

On May 20, the Chinese communist regime’s Xinhua News Agency reported that Chinese vaccines Sinovac, Sinopharm, and CanSino, are being administered on a large scale in Latin American countries such as Brazil, Chile, Mexico, Argentina, and Peru.

According to the latest statistics from the PAHO, the report also said that as of May 14, 26 Latin American and Caribbean countries had received more than 84 million doses of the vaccine. Of these, nearly 55 million doses—or around 65 percent—were Chinese vaccines.

NBC reported on May 23 that China has shipped more than 165 million doses of Chinese vaccines to Latin America and the Caribbean in recent months.

Gao Fu, director of the China Centers for Disease Control, speaks during a State Council Information Office press conference in Beijing, China on January 26, 2020. (Noel Celis/AFP via Getty Images)

The report quoted experts as saying that the Chinese Communist Party (CCP) is using vaccines to advance its agenda in Latin America. Latin American officials have also noted that the CCP has asked Latin America to cut ties with Taiwan in exchange for the vaccine.

Many countries in South and Central America and the Middle East that have embraced Communist China’s “vaccine diplomacy,” including Brazil, Chile, Pakistan, and Turkey, have seen a spike in confirmed viral infections and strong side effects among vaccine recipients after widespread administration of the Sinovac vaccine.

Chinese Centre for Disease Control and Prevention head Gao Fu at a news conference on the Wuhan coronavirus in Beijing, 22 January 2020. Gao released a paper suggesting that the authorities knew of human-to-human transmission of the coronavirus but did not reveal that information. (Jason Lee/Reuters)

On April 10, at the Chinese national conference on vaccines and health, Gao Fu, Director of China’s Center for Disease Control and Prevention, admitted that China’s vaccines do not offer much protection and that the effectiveness should be improved by using several vaccines in an alternating fashion.

In January this year, the Instituto Butantan, a leading Brazilian producer of vaccines, Brazil lowered the effectiveness rate of the Sinovac vaccine from 77.96 percent to 50.38 percent and in March. Three phases of clinical trials in Peru of the Sinopharm vaccine showed that the vaccine by Beijing Bio, a subsidiary of Sinopharm, was only 11.5 percent effective; Wuhan Bio’s vaccine was 33 percent effective, far below the CCP’s claim of nearly 80 percent.

Source: The Epoch Times